GSK239512
Drug timelines are a Plus or Pro feature.
6 regulatory and trial events tracked for GSK239512, covering 2012-06-04 to 2017-09-27. Get the full timeline:
Most recent: Clinical Trial Update: Study to Evaluate the Efficacy and Safety of GSK239512 in Schizophrenia [Phase 2]